2017\u5e748\u670822\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001DIA\uff08Drug Information Association\uff09\u5e74\u6b21\u7dcf\u4f1a\u306b\u304a\u3044\u3066\u3001 \u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u30e2\u30c7\u30eb\u3078\u5411\u304b\u3046\u9867\u5ba2\u306e\u52d5\u304d\u3092\u80cc\u666f\u3068\u3057\u3066\u3001³Ô¹Ï±¬ÁÏ Vault CTMS<\/strong><\/a>\u306e\u63a1\u7528\u304c\u52a0\u901f\u3057\u3066\u3044\u308b\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u88fd\u54c1\u306e\u30ea\u30ea\u30fc\u30b9\u304b\u3089\u308f\u305a\u304b2\u304b\u6708\u3067\u3001\u4e16\u754c\u306e\u88fd\u85ac\u4f01\u696d\u30c8\u30c3\u30d750\u306b\u30e9\u30f3\u30af\u30a4\u30f3\u3059\u308b1\u793e\u3092\u542b\u30805\u793e\u304c\u3001³Ô¹Ï±¬ÁÏ Vault CTMS\u3092\u5c0e\u5165\u3057\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Vault CTMS\u306f\u3001\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u5168\u4f53\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30c7\u30fc\u30bf\u3001\u30b3\u30f3\u30c6\u30f3\u30c4\u3001\u30d7\u30ed\u30bb\u30b9\u3092\u7d71\u5408\u5316\u3059\u308b\u3001\u696d\u754c\u521d\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u3059\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n \u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u5c02\u9580\u5bb6\u3092\u5bfe\u8c61\u3068\u3057\u305f\u696d\u754c\u6700\u5927\u306e\u8abf\u67fb\u306e\u3072\u3068\u3064\u3067\u3042\u308b\u3001³Ô¹Ï±¬ÁÏ 2017 Unified Clinical Operations Survey<\/strong><\/a>\u306b\u3088\u308c\u3070\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306f\u3001\u65e7\u6765\u306eCTMS\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306b\u304a\u3051\u308b\u69d8\u3005\u306a\u8ab2\u984c\u306b\u76f4\u9762\u3057\u3066\u3044\u307e\u3059\u3002\u307b\u307c\u3059\u3079\u3066\u306e\u6cbb\u9a13\u4f9d\u983c\u8005\u304c\u3001CTMS\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u3063\u3066\u3001\u7d44\u7e54\u306b\u304a\u3051\u308b\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u6539\u5584\u304c\u5236\u9650\u3055\u308c\u3066\u3044\u308b\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u203b<\/sup>\u3002\u305d\u306e\u305f\u3081\u3001\u696d\u52d9\u5168\u4f53\u3092\u901a\u3057\u3066\u30d7\u30ed\u30bb\u30b9\u3092\u7d71\u5408\u5316\u3057\u3001\u5358\u4e00\u306e\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u3068\u60c5\u5831\u3092\u5229\u7528\u3067\u304d\u308b\u3088\u3046\u306b\u3057\u3088\u3046\u3068\u3059\u308b\u53d6\u308a\u7d44\u307f\u3078\u3068\u3064\u306a\u304c\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Vault CTMS\u306e\u65b0\u898f\u9867\u5ba2\u3067\u3042\u308b\u3001inSeption Group\u306e\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Lynn Sutton\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ Vault CTMS\u306f\u3001\u4f7f\u3044\u3084\u3059\u3055\u3068\u76f4\u611f\u7684\u306a\u30c7\u30b6\u30a4\u30f3\u306b\u3088\u3063\u3066\u3001\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306b\u65b0\u6642\u4ee3\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u78ba\u7acb\u3057\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306b\u306f\u9867\u5ba2\u3092\u6210\u529f\u306b\u5c0e\u3044\u3066\u304d\u305f\u5b9f\u7e3e\u304c\u3042\u308a\u307e\u3059\u3002\u6211\u3005\u306e\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u304c\u52b9\u7387\u5316\u3055\u308c\u308b\u3053\u3068\u306b\u3088\u3063\u3066\u3001\u65b0\u3057\u3044\u6b21\u5143\u306e\u52b9\u7387\u6027\u3068\u751f\u7523\u6027\u3092\u5b9f\u73fe\u3067\u304d\u308b\u3053\u3068\u3092\u671f\u5f85\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n \u696d\u754c\u5168\u4f53\u3067\u3001\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u30e2\u30c7\u30eb\u3078\u3068\u5411\u304b\u3046\u50be\u5411\u304c\u898b\u3089\u308c\u307e\u3059\u3002\u4f01\u696d\u306f\u3001\u8fc5\u901f\u306a\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u304a\u3088\u3073\u81e8\u5e8a\u8a66\u9a13\u54c1\u8cea\u306e\u5411\u4e0a\u306e\u305f\u3081\u3001\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u5168\u4f53\u3067\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u7d71\u5408\u5316\u306e\u5fc5\u8981\u6027\u306b\u3064\u3044\u3066\u8a00\u53ca\u3057\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u5927\u591a\u6570\u306e\u4f01\u696d\u306fCTMS\u3068\u4ed6\u306e\u81e8\u5e8a\u958b\u767a\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3068\u306e\u7d71\u5408\u306b\u8ab2\u984c\u3092\u62b1\u3048\u3066\u304a\u308a\u3001\u696d\u52d9\u306e\u6539\u5584\u304c\u5236\u9650\u3055\u308c\u3066\u3044\u307e\u3059\u203b<\/sup>\u3002<\/p>\n \u5148\u65e5³Ô¹Ï±¬ÁÏ Vault CTMS\u306e\u9867\u5ba2\u3068\u306a\u3063\u305fOra Inc\u306e\u81e8\u5e8a\u60c5\u5831\u30b7\u30b9\u30c6\u30e0\u30de\u30cd\u30b8\u30e3\u30fc\u3001Edward Leftin\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cCTMS\u3001eTMF\u3001study start-up\u3092\u73fe\u4ee3\u7684\u306a\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u7d71\u5408\u3059\u308b\u6a5f\u80fd\u306f\u3001\u307e\u3055\u306b\u5927\u304d\u304f\u6642\u4ee3\u3092\u5909\u3048\u308b\u3082\u306e\u306b\u306a\u308a\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u3059\u3079\u3066\u306e\u81e8\u5e8a\u8a66\u9a13\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3092\u901a\u3057\u3066\u3001\u540c\u3058\u30d3\u30b8\u30cd\u30b9\u30d7\u30ed\u30bb\u30b9\u3068\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3092\u6700\u5927\u9650\u306b\u6d3b\u7528\u3055\u305b\u3066\u304f\u308c\u308b\u3067\u3057\u3087\u3046\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ Vault CTMS\u306f³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/strong><\/a>\u306e\u4e00\u90e8\u3067\u3001EDC\u3001eSource\u3001CTMS\u3001eTMF\u3001study start-up\u3001\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3068\u306e\u6587\u66f8\u6388\u53d7\u3092\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u7ba1\u7406\u3068\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u7d71\u5408\u3059\u308b\u3001\u696d\u754c\u552f\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u53ef\u8996\u5316\u3055\u308c\u305f\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30bb\u30b9\u3068\u60c5\u5831\u3092\u7d71\u5408\u3055\u308c\u305f\u3072\u3068\u3064\u306e\u30b7\u30b9\u30c6\u30e0\u3067\u63d0\u4f9b\u3057\u3001\u30c1\u30fc\u30e0\u3092\u5f37\u5316\u3057\u307e\u3059\u3002\u4eca\u3084\u3001\u4f01\u696d\u306f\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306e\u81e8\u5e8a\u8a66\u9a13\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u5bb9\u6613\u306b\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u60c5\u5831\u306b\u57fa\u3065\u3044\u305f\u3088\u308a\u826f\u3044\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Vault\u306e\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Jennifer Goldsmith\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u3053\u306e\u696d\u754c\u306f\u3001\u30b5\u30a4\u30ed\u5316\u3055\u308c\u305f\u30d7\u30ed\u30bb\u30b9\u3068\u30b7\u30b9\u30c6\u30e0\u306b\u3088\u3063\u3066\u3001\u4f55\u5341\u5e74\u3082\u505c\u6ede\u3057\u3066\u304d\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Vault Clinical Suite\u306b\u5bfe\u3059\u308b\u9867\u5ba2\u306e\u53cd\u5fdc\u306f\u3001\u5727\u5012\u7684\u306b\u80af\u5b9a\u7684\u3067\u3059\u3002\u306a\u305c\u306a\u3089\u3001\u30d7\u30ed\u30bb\u30b9\u3092\u7d71\u5408\u5316\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u3068\u54c1\u8cea\u3092\u6539\u5584\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3067\u306e\u77e5\u898b\u3092\u5f97\u308b\u3053\u3068\u304c\u3001\u521d\u3081\u3066\u53ef\u80fd\u306b\u306a\u3063\u305f\u304b\u3089\u3067\u3059\u3002\u300d<\/p>\n \u203b³Ô¹Ï±¬ÁÏ 2017 ³Ô¹Ï±¬ÁÏ 2017 Unified Clinical Operations Survey\uff08³Ô¹Ï±¬ÁÏ Systems)\u30012017\u5e746\u670819\u65e5<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2017\u5e748\u670822\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-40494","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-veeva-rd"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40494"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=40494"}],"version-history":[{"count":6,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40494\/revisions"}],"predecessor-version":[{"id":40501,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40494\/revisions\/40501"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=40494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=40494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=40494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067500\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/span>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April 30, 2017. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"